Fig. 1

Data are mean ± SEM for P2 latency alterations of VEP in in different groups. a–f: P2 latency of VEP. Black arrow indicates P2 latency (ms). a: Normal group. b: Infected group by A. cantonensis (21 dpi). P2 latency is prolonged (>100 ms, ↓points). c: Albendazole (AB) treatment for 7 days after 14 dpi with A. cantonensis. P2 latency still is prolonged (>100 ms, ↓points). d: Albendazole combined with Dexamethasone (De) treatment for 7 days after 14dpi with A. cantonensis. P2 latency is still prolonged (>100 ms, ↓points). e: Albendazole combined with CPT treatment for 7 days after 14 dpi with A. cantonensis. P2 latency recovered to normal. f: Albendazole combined with TSII-A treatment for 7 days after 14 dpi with A. cantonensis. P2 latency recovered to normal. g: Data are mean ± SEM of P2 latency of mice in different treatment groups for 7 days after 14 dpi with A. cantonensis. *Statistically significant when compared with normal control (P < 0.05); #Statistically significant when compared with 21 dpi with A. cantonensis, n = 5 per group, P < 0.05